Newfoundland and Labrador

Cancer care runs through the NL Health Services Provincial Cancer Care Program, in operation with budget lines for travel support (MTAP), telehealth, and oncology investment; pancreatic cancer sits within general oncology — no dedicated pancreatic program exists.

The provincial laboratory formulary funds BRCA1/2 and hereditary colorectal panels (the entry is dated 2019, the oldest in the national inventory); broader comprehensive genomic profiling typically requires send-out testing or interprovincial arrangements.

NL has no income-based drug program equivalent to Ontario's Trillium. This score rests on the Atlantic regional figure — up to 59% of take-home oncology medicine spending was privately paid in the Atlantic groupings vs 12% in Alberta (PMPRB 2021, 2019 data); no NL-specific figure was obtainable.

A provincial Teleoncology program operates across all regions, NL is one of three CRAFT pilot provinces for decentralized trials, and a satellite research site runs in Grand Falls–Windsor; pancreatic trial access in the region is nonetheless assessed as "extremely limited".

Pancreatic and HPB surgery is provided in-province at a single centre (Health Sciences Centre / Bliss Murphy, St. John's). Not obtainable: no NL-specific wait-time figure exists in the inventories; the only numeric waits are PEI (77.4 weeks) and NS (39.1 weeks), 2024 editions.

MTAP cost-shares airfare, mileage, accommodations, and meals for eligible out-of-area care (referral required); student assessors rated it 3 of 5, citing the up-front payment burden, and Daffodil Place lodging 5 of 5. Cash-flow stress for rural and Labrador patients travelling to St. John's is documented as capable of delaying treatment starts.

Oncology registered nurses serve as patient navigators in Labrador-Grenfell. The NL Rural Physician Incentive is rated "partially adequate" for recruitment, with retention weak — flagged especially for NL and NB — and allied health excluded.

No CIHR pancreatic-cancer grant is hosted at an NL institution — 0 of 88 records nationally. NL participates in regional research collaboration as one of the four Atlantic Cancer Consortium provinces and holds national-body representation, including an NL physician on 3CTN's Management Committee and a Memorial University public representative on NACI.